Presentation is loading. Please wait.

Presentation is loading. Please wait.

{ USC pathways, haematuria and PSA. Mr. Babbin S. John FRCS (Urol), CUH/SGH.

Similar presentations


Presentation on theme: "{ USC pathways, haematuria and PSA. Mr. Babbin S. John FRCS (Urol), CUH/SGH."— Presentation transcript:

1 { USC pathways, haematuria and PSA. Mr. Babbin S. John FRCS (Urol), CUH/SGH

2  1607 referrals in the year to September 2015  All urological cancer referrals  30 DNAs - returned to GP. USC pathways

3  Overall yield of new cancers was 16.5%  This is in line with contemporary literature.  In the last year 3% of patients waited beyond 14 days  Emphasis on seeing within 7 days Yield

4 Haematuria guidelines

5

6

7 +ED + visible haematuria

8  Urgent referral for visible haematuria without infection (or after treatment) in over 45s  Consider a non-urgent bladder cancer referral in those with recurrent or persistent urinary tract infection. Nice guidelines

9 Information

10  At risk groups  BME - Afro-Caribbean (x2 risk)  Family history, by age (single 1st-degree member x2 risk) PSA testing

11  Deprivation  Cultural restrictions including language  Lack of access  Non-threatening environment Targeting

12

13  Q & A


Download ppt "{ USC pathways, haematuria and PSA. Mr. Babbin S. John FRCS (Urol), CUH/SGH."

Similar presentations


Ads by Google